Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Carrick Therapeutics
company
About
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
- Dublin,Dublin,Ireland
- 51 - 100
- http://www.carricktherapeutics.com/
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $60M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- Carrick Therapeutics Limited
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$155M
Carrick Therapeutics has raised a total of
$155M
in funding over 2 rounds. Their latest funding was raised on
Dec 1, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2022 | Series C | $60M | 7 |
Pfizer
|
— | Detail |
| Oct 3, 2016 | Series A | $95M | 7 |
ARCH Venture Partners
Woodford Investment Management
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
9
Carrick Therapeutics is funded by 9 investors.
Pfizer
and Woodford Investment Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Pfizer
|
Yes | Series C |
|
Woodford Investment Management
|
Yes | Series A |
Evotec
|
— | Series C |
|
ARCH Venture Partners
|
— | Series C |
Cambridge Innovation Capital
|
— | Series C |
GV
|
— | Series C |
|
|
— | Series C |
Rosetta Capital
|
— | Series C |
University of Cambridge Enterprise
|
— | Series A |
Employee Profiles
Number of Employee Profiles
12
Carrick Therapeutics has 12 current employee profiles, including
Board member Steven Gillis
Board member
Board member
Board member
Employee
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
